Skip to content

Category: Video

Watch Now: A Path for Early Detection 

On March 29th, Friends of Cancer Research (Friends) convened a virtual meeting to discuss the use of multi-cancer early detection (MCED) screening tests, a promising technology that may support earlier detection of cancers. Dr. Ellen Sigal, Friends’ chair and founder, opened the meeting by highlighting the potential for MCED screening tests to shift the trajectory…

Watch Now: Supporting Development of Diagnostic Tests for Unmet Needs

On Tuesday, February 22, 2022, Friends of Cancer Research (Friends) hosted a live virtual event that brought together leading voices from various health sectors to discuss key considerations for developing diagnostics tests for rare populations of patients, including those with rare diseases and rare biomarkers. The meeting covered topics surrounding the findings from a recent…

Watch Now: “Beyond Breakthrough: Optimizing the Breakthrough Therapy Designation” 

On Monday, September 20th, 2021, Friends of Cancer Research (Friends) hosted a virtual event that brought together industry experts, the U.S. FDA, and patient advocates to discuss improving the Breakthrough Therapy designation (BTD) program. The panelists outlined opportunities to enhance the existing expedited drug development programs, including specific recommendations for the BTD, as outlined in…

Senate Briefing – Turning the Tables: Innovator Meets Regulator

At a Senate briefing hosted by Friends of Cancer Research (Friends), a panel comprised of leading stakeholders convened to discuss changes in cancer care and criticisms of the U.S. Food and Drug Administration’s (FDA) expedited approval programs. As recent advancements to discover and develop targeted therapies, immunomodulating agents, and cell-based therapies provide new and potentially…

22nd Annual Cancer Leadership Awards Reception

This year’s awardees at the 22nd Annual Cancer Leadership Awards Reception From L-R: Dr. Anthony Fauci, Dr. Richard Klausner September 21, 2018 The Hay-Adams 800 16th St NW, Washington, DC 20006 On September 21, 2018, Friends of Cancer Research (Friends) hosted the 22nd Annual Cancer Leadership Awards Reception. The yearly event brings together leaders in…

A Plea to Make Cancer Clinical Trials More Patient Friendly

Jim Omel is a myeloma patient and a cancer research advocate. He spoke at the 2017 Friends of Cancer Research Annual Meeting and was an author of the panel 2 whitepaper, Data Generation to Support Cross-Labeling of Indications for Combination Products. Below are his abridged remarks from the meeting. To view his remarks in full,…

The Magic of Summer at Camp Fantastic

With summer now behind us, we thought it would be a good time to reflect on one of the special experiences our science policy analyst, Diana Merino, had over the summer… This summer, for the second year in a row, I got to spend a week volunteering at Camp Fantastic, a camp that provides an…

Fighting to Change the Cancer Story

Friends of Cancer Research Vice President – Public Affairs, Ryan Hohman, shares why he is passionate about the Friends mission of bringing life-saving treatments to patients in the fastest and safest way possible in the latest installment of “My Story.” From a young age, Ryan has been witness to how cancer impacts families and saw what he…

Tough as Hell – A Breast Cancer Fighter Tells Her Story

In November 2014, assistant professor, Jenna Kieckhaefer, was diagnosed with breast cancer. She was only 28 years old at the time.     The concept of having breast cancer first came to Jenna’s attention when she was working on her PhD. She went for an annual visit and was informed she had lumpy breasts. While…

David Baltimore Talks Cancer, Research, and How Things Have Changed Since He Was in High School

David Baltimore is a world-renowned biologist who in 1975 won the Nobel Prize in physiology or medicine along with Howard Temin and Renato Dulbecco “for their discoveries concerning the interaction between tumor viruses and the genetic material of the cell.” We had the chance to sit down and discuss science, cancer research, and more with…